Featured
Coronavirus: NAFDAC Approves Production Of Chloroquine For Clinical Trial
TRACKING_____The National Agency for Food and Drug Administration and Control (NAFDAC) has approved the production of Chloroquine for clinical trials in the search for a cure for COVID-19.
Director-General of the agency, Mojisola Adeyeye, made the announcement on Friday at the NAFDAC headquarters in Lagos.
She, however, pointed out that NAFDAC is not approving Chloroquine for the treatment of COVID-19 but for clinical trials to find treatment for the virus.
“NAFDAC is not approving Chloroquine as a product that has can be used for Coronavirus because there is no submission to us for registration but because it is under clinical trials, NAFDAC approves medicines meant for clinical trials.
“Therefore the medicine is being approved just for the clinical trials,” Adeyeye said.
She, therefore, called on experts and researchers that are interested in doing a clinical trial on Chloroquine to approach approved outlets.
“Right now, we have asked one company to make a batch of Chloroquine for the purpose of clinical trial,” Adeyeye added.
-
Gist4 days ago
My Boss Used To ‘KNACK’ My Wife After Sending Me On A Mission, To The Extent She Got… – Ex-soldier
-
News3 days ago
Cooking Gas Price Has Fallen
-
Politics4 days ago
Revealed: What Access Bank Said About Its Dealings With Yahaya Bello
-
News6 days ago
Fake Reverend Sister Arrested With 38 Children
-
News3 days ago
Read How Auxiliary Was Whisked Away By Masked Security Agents as Family member Speaks
-
Sports3 days ago
Finidi agrees deal with NFF, names three foreign assistants
-
Politics3 days ago
Atiku Says Tinubu’s Son Is A Director In Company Related To Coastal Road Contract
-
News3 days ago
Governor Diri Hails FG Over Siting of Oil and Gas Institute in Bayelsa